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TryptophanTwenty years ago, the discovery of peptides able to cross cellular membranes launched a novel ﬁeld
in molecular delivery based on these non-invasive vectors, most commonly called cell-penetrating
peptides (CPPs) or protein transduction domains (PTDs). These peptides were shown to efﬁciently
transport various biologically active molecules inside living cells, and thus are considered promising
devices for medical and biotechnological developments. Moreover, CPPs emerged as potential tools
to study the prime mechanisms of cellular entry across the plasma membrane. This review is ded-
icated to CPP fundamentals, with an emphasis on the molecular requirements and mechanism of
their entry into eukaryotic cells.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Cell-penetrating peptides: what are they?
The identiﬁcation of proteins that can enter cells was ﬁrst re-
ported in the late eighties, contradicting the acknowledged under-
standing that the plasma membrane is impermeable to hydrophilic
molecules. Thus, it has been demonstrated that the Trans-Activator
of Transcription (Tat) protein of the Human Immunodeﬁciency
Virus was able to efﬁciently enter tissue-cultured cells and pro-
mote the viral gene expression [1,2]. Moreover, Antennapedia
homeodomain, a transcription factor of Drosophilia melanogaster,
was also shown to enter nerve cells and regulate neural morpho-
genesis [3]. The interesting spontaneous entry of both proteins
led to extensive structure/function studies to ﬁnd the shortest ami-
no acid sequence necessary for the uptake. This resulted in the
identiﬁcation of the ﬁrst CPPs: Tat peptide, corresponding to the
basic domain of HIV-1 Tat protein [4,5] and penetratin, corre-
sponding to the third helix of the Antennapedia homeodomain
[6]. Ever since, various peptides showing the same penetrating
capacities have been discovered or rationally designed.1.1. Deﬁnition and classiﬁcation of CPPs
The ﬁeld of CPPs evolved rapidly, ever since the ﬁrst sequences
were described. This makes it hard to have a general deﬁnition cov-
ering the characteristics of the different CPPs discovered. So far, one
can say that CPPs are short peptides (generally not exceeding 30 res-
idues) that have the capacity to ubiquitously cross cellular mem-
branes with very limited toxicity, via energy-dependent and/or
independent mechanisms, without the necessity of a chiral recogni-
tion by speciﬁc receptors. Most common CPPs are positively charged
peptides, though the presence of few anionic or hydrophobic CPPs
was also demonstrated. A primary or secondary amphipathic charac-
ter is also implicated but not strictly required for the internalization.
According to their origin, we can distinguish three main classes
of CPPs: peptides derived from proteins, chimeric peptides that are
formed by the fusion of two natural sequences, and synthetic CPPs
which are rationally designed sequences usually based on struc-
ture–activity studies (Table 1). Other attempts to classify CPPs, in
spite of their diversity, were based on the physico-chemical char-
acteristics of the sequences (e.g., their amphipathicity [7], or their
hydrophobicity [8]). A recent review summarizes the different
classiﬁcations and the physico-chemical properties of the so-far
described CPPs [9].1.2. Applications
CPPs can transport inside living cells a variety of covalently
or non-covalently linked cargoes, as has been reviewed for
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gonucleotides [20,22], small interfering RNA [23], double stranded
DNA [18] and liposomes [18].
The transport of the smallest cargo to large 120 kDa proteins
had been successfully carried out both in vitro and in vivo. For in-
stance, activable CPPs (ACPPs) were recently employed in vivo to
target cancer cells over-expressing metalloproteinase-2 [24], while
treatment of various inﬂammatory diseases by inhibition of NF-jB
was also effective in vivo by coupling the inhibitors to different
CPPs [25]. Tumor-targeting was also achieved in vivo for the
(D)R8–doxorubicin conjugate [26]. It is difﬁcult to keep track of
the various applications because the ﬁeld is emerging rapidly. Re-
cently, a novel class of intrinsically bioactive CPPs, baptized bio-
portide, made an appearance with the description of a CPP
sequence derived from cytochrome c that mimicked the apoptotic
role of the entire protein once it entered inside cells [27,28]. An-
other in vitro study on mouse neuronal hypothalamic cells re-
vealed that the N-terminal sequence derived from the prion
protein could penetrate cells and disabled the formation of prions
[29].
2. Entry into cells: how do they do it?
Studies in the ﬁeld of CPPs evolve around three research areas:
(i) using CPPs as vectors to transport various macromolecules
in vitro and in vivo for targeted cellular therapies, (ii) deﬁning
the structural basis of the internalization capacities in order to
engineer new CPPs with optimum activity, (iii) elucidating the
mechanisms of cell entry that remain subject of controversy in
the literature. These different areas are tightly connected because
in order to better use CPPs as vectors, one should understand
how these peptides are crossing cellular membranes: what are
the structural requirements, how do they interact with the various
cellular components to drive their way inside the cells, and what
are their ﬁnal localizations.
2.1. Methods to study the mechanism of CPP uptake: in search for the
perfect technique?
Various biological and biophysical methods are used to study
the internalization mechanism, to localize and to quantify CPPs
and their cargoes inside cell. Yet, every method has its pitfall and
in order to have access to the large picture one should use a com-
bination of different approaches.
2.1.1. In cellulo approaches
Studies in the cellular context mainly aim to follow the CPP and/
or the cargo uptake, or to reveal the molecular mechanisms of the
internalization. The methods used are generally indirect, based on
ﬂuorescence (and to a lesser extent on radiolabelling) or on the
detection of the biological activity of the cargo [30]. Another meth-
od that enables direct quantiﬁcation of the intact CPPs inside the
cells or bound to the cellular membranes had been developed,
based on matrix-assisted laser desorption-time of ﬂight mass spec-
trometry (MALDI-TOF MS) [31,32]. Other biophysical approaches
are also used in living cells, such as electron microscopy to study
membrane structures induced by CPPs and the peptides distribu-
tion [33,34] and in cell Raman spectroscopy to reveal the peptide
secondary structure in cellular compartments [35].
2.1.1.1. Fluorescence-based protocols. These are the most common
methods used. The peptides are covalently coupled to a ﬂuoro-
phore and measuring the ﬂuorescence (ﬂuorimetry) will enable
indirect quantiﬁcation of the peptides, while confocal microscopy
allows localizing the probes inside living cells. Though convenient,many drawbacks of such methods exist. For instance, the indirect
detection through the ﬂuorescent label does not allow deﬁning if
the peptide is still linked to the ﬂuorescent probe once inside cells;
thus, the molecular integrity of the internalized entities cannot be
demonstrated. Moreover, quenching of the ﬂuorescence due to the
accumulation in subcellular compartments and transitory binding
partners may also lead to inaccurate results [36]. In addition, CPP
functionalization by ﬂuorophores changes the physico-chemistry
of the peptides, thus inﬂuences negatively or positively their inter-
nalization efﬁciency and increases their toxicity (cf. Box 1). Indeed
ﬂuorophores are not only hydrophobic moieties but some of them
also contain negative charges that change the overall net charge of
CPPs. For example, carboxyﬂuorescein can introduce two negative
charges on peptides since ﬂuorescein contains a carboxylic acid
and is generally added at the N-terminal primary amine of peptide
sequences.Box 1 CPP labeling effect. Beside other experimental fac-
tors that affect the uptake mechanism (cell type, incubation
time, temperature . . . ), the label attached covalently or non-
covalently to the CPPs will definitely influence the interaction
and the subsequent mechanism of internalization of the stud-
ied peptides. Fluorophores, for example, are generally highly
hydrophobic and are shown to greatly modify the interaction
with the lipid bilayer [34,41], to increase the uptake as well as
to affect the cellular distribution of the CPPs [37,42,43]. More-
over, it was demonstrated that fluorophores change the flex-
ibility and the conformation of the peptides [44]. Biotin on the
other hand is generally less hydrophobic than the commonly
used fluorophores, and was shown not to affect the interac-
tion with model membranes [45]. Nevertheless, the presence
of specific transporters for biotin was described in some cell
lines like intestinal and hepatic cells, and was used to im-
prove the delivery of macromolecules [46,47].
Thus, the physico-chemical characteristics of the probe
should always be taken into consideration when assessing
the mechanisms of internalization. However, the fact that
our interest in CPPs relies on their vectorization capacities,
adding a probe will give us information about conjugated
CPP-cargo behavior. Yet, this does not exclude the impor-
tance of deciphering the molecular basis of the peptides/cells
interactions because A to Z analysis of every CPP-cargo is not
the solution for a rapid development of the field of
applications.
An indirect protocol has been developed to study the intracellu-
lar localization of CPPs, which does not require their labeling with
ﬂuorophores [37]. This approach is based on CPP staining once in-
side cells, by using for example biotin–streptavidin interaction.
Biotinylated peptides are thus stained by streptavidin-coupled
ﬂuorophores. But this involves cell ﬁxation, which is believed to in-
duce artifactual results due to a non-efﬁcient ﬁxation [38], allow-
ing vesicle entrapped and membrane-bound peptides and
proteins to be redistributed in new cellular compartments (mainly
cytosolic) after the permeabilization step [38–40].
Finally, an important point should also be kept in mind when
using ﬂuorescence-based protocols, which is the necessity to elimi-
nate the membrane-bound CPPs before any analysis. Methods to re-
duce signals from surface bound CPPs, such as quenching of surface-
bound ﬂuorophores, heparin washings and trypsin treatments, are
generally employed. For instance, in the protocol described above
based on staining of internalized biotinylated CPP, the membrane-
bound peptide is quenched by unlabelled avidin [37].
2.1.1.2. Functional assays in cells. In order to get a direct read-out of
the peptide entry into cells, methods to detect the biological activ-
Table 1
Origin and sequences of some of the studied CPPs.
Peptide Origin Sequence Reference
Protein-derived
Penetratin Antennapedia (43–58) RQIKIWFQNRRMKWKK [6]
Tat peptide Tat(48–60) GRKKRRQRRRPPQ [5]
pVEC Cadherin(615–632) LLIILRRRIRKQAHAHSK [10]
Chimeric
Transportan Galanine/Mastoparan GWTLNSAGYLLGKINLKALAALAKKIL [11]
MPG HIV-gp41/SV40 T-antigen GALFLGFLGAAGSTMGAWSQPKKKRKV [12]
Pep-1 HIV-reverse transcriptase/SV40 T-antigen KETWWETWWTEWSQPKKKRKV [13]
Synthetic
Polyarginines Based on Tat peptide (R)n; 6 < n < 12 [14,15]
MAP de novo KLALKLALKALKAALKLA [16]
R6W3 Based on penetratin RRWWRRWRR [17]
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[48,49]. These approaches are indeed very appropriate for the pur-
pose of therapeutic and biotechnological applications. Neverthe-
less, measuring the biological activity of the cargo introduces
many parameters such as the afﬁnity of the cargo for its intracellu-
lar target, the efﬁciency of cargo modiﬁcation by the target and po-
tential reversibility of the enzymatic reaction, which hamper the
rationalization of the results and complicate the analysis of the
internalization mechanism.
A widely used example is the splicing redirection assay [50,51],
where CPPs are used to internalize antisense ONs whose activity
results in the upregulation of the luciferase gene expression. The
splicing reporter systemworkers consist on a recombinant plasmid
(pLuc/705) carrying the luciferase gene interrupted by a mutated
human b-globin intron 2 (IVS2-705). The mutation in the intron
causes aberrant splicing of luciferase pre-mRNA, preventing trans-
lation of luciferase. However, if the aberrant splice site is masked
by antisense ONs the pre-mRNA of luciferase will be properly pro-
cessed, yielding to the expression of the protein whose activity can
be evaluated by luminescence. Stably transfected HeLa pLuc 705
cells have been used to evaluate the CPP-based delivery of various
ONs, as well as to gain insight on the mechanisms of internaliza-
tion [52–54].
Another system is based on the Cre-mediated recombination of
an enhanced green ﬂuorescent protein (EGFP)-reporter gene giving
rise to expression of EGFP. The recombination can only take place
upon exogenous Cre-protein delivery to the nucleus [55,56].
2.1.1.3. Quantiﬁcation of internalization in cells. An approach relying
on MALDI-TOF MS was developed in our laboratory in order to
quantify the amount of internalized peptides inside living cells
[31,32]. Moreover, we can have access to the amount of both inter-
nalized and plasma membrane-bound peptides. MALDI-TOF MS is
a very sensitive method, with limits of detection in the femtomole
range. To get an absolute quantiﬁcation in biological samples, we
should surpass sample heterogeneity that may lead to signal sup-
pression. Moreover, an internal standard is required, because the
ionization and the detection in MALDI are strongly dependent on
the nature of the molecule studied. For that, the CPPs are synthe-
sized with a spacer of four glycines on the N-terminus ([1H]CPP),
bearing a biotin tag for puriﬁcation purposes. The spacer will allow
us obtaining the internal standard peptide, where the four glycines
are bideuterated ([2H]CPP). This helps overcoming the risk of
molecular discrimination between the analyte ([1H]CPP) and the
internal standard ([2H]CPP) during puriﬁcation, sample prepara-
tion for MS analysis and the desorption–ionization steps.
With this method, the quantity or concentration of peptide
internalized together with its molecular integrity (intact or de-
graded) can be determined within the same experiment. In addi-
tion, by using proteolytic digestion, we can discriminate betweenthe amount of membrane-bound and internalized peptides since
10–100 fold differences between those two amounts are generally
observed [57–60]. The disadvantage of this method is that it does
not give any information about the intracellular localization of
the peptide. However it proved to be valuable to decipher the
mechanisms of internalization (endocytosis versus direct translo-
cation) and compare the relative internalization efﬁciencies of
CPPs.
2.1.2. In vitro approaches the usefulness of antimicrobial peptides
For in vitro approaches, the CPP ﬁeld have particularly beneﬁted
from the ﬁeld of antimicrobial peptides (AMPs). These two peptide
families should indeed be considered as related membrane-active
peptides [61]. Most of CPPs and AMPs are positively charged, and
the majority of AMPs are also amphipathic a-helices. The relative
contribution of the positively charged and hydrophobic domains
is very important for the membrane activity of AMPs [62]. Upon
interaction of AMPs with membranes, the positive charges cluster
at the lipid–peptide interface establishing strong electrostatic
interactions with the negatively charged phospholipid membrane
of pathogens. The non-polar face of the peptides will then insert
into the membrane through hydrophobic interactions, and cause
increased permeability of the membrane through different pertur-
bation mechanisms [63].
As for AMPs, various biophysical approaches are employed to
analyze in vitro the molecular interactions between CPPs and cel-
lular components, such as carbohydrates and lipids, in order to sur-
pass the complexity of the biological systems. Methods with model
membranes or lipid bilayers have been widely used to determine
the interaction, insertion and direct translocation of CPPs through
the inert plasma membrane [64]. Peptide secondary structure fol-
lowing interaction with lipids or polysaccharides was also studied
mainly by circular dichroism and infrared spectroscopy [60,65,66].
Most in vitro studies of membrane translocation by CPPs rely on
ﬂuorescence techniques [67] with the same pitfalls as described for
studies with cells. However, other techniques that do not require
labeling of the CPP sequences brought a lot of information regard-
ing membrane perturbation or supramolecular reorganization
events that are evoked by these peptides: 31P NMR, differential
scanning calorimetry, calcein or ﬂuorescein-entrapped liposome
leakage and small angle X-ray scattering [7,59,60,68,69]. For all
these assays, membrane models are used.
The curvature of the bilayers is important for the membrane
behavior of CPPs. Several studies using large or giant unilamellar
vesicles (LUV and GUV) have been reported to analyze the translo-
cation properties of CPPs. LUVs are vesicles classically obtained by
extrusion of multilamellar vesicles. With the size of 100 nm, LUVs
are considered as vesicles with little or no defects and widely used
for translocation studies of ﬂuorescent-labeled peptides or calcein
leakage assays. LUVs with smaller size (50 nm) can be assimilated
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are vesicles larger than 1–10 lm diameter that can be obtained by
spontaneous formation or by electroformation, and are assimilated
as models for cell plasma membrane. More recently, giant vesicles
derived from the plasma membrane of cells were used by Pooga
and co-workers to study the internalization of six classical CPPs.
The composition of these vesicles mimics the one of the cell mem-
branes yet lacks the machinery necessary for endocytosis [71].
Penetratin internalized into GUVs and not into LUV except in
the presence of a transbilayer potential [72–74]. More evidence
was added for transmembrane translocation dependence on trans-
bilayer potential of penetratin, with a light-generated proton
pumping system in LUVs [75]. The same methodology, with bacte-
riorhodopsin (BR) asymmetrically introduced into large unilamel-
lar vesicles (LUVs), was used to induce a pH gradient across the
lipid bilayer that was shown to facilitate membrane translocation
for intermediately hydrophobic CPPs (pVEC, M918), and much less
for hydrophilic CPPs (Tat, R9) [76]. Membranes of GUVs are more
ﬂexible than typical LUVs, and topical, positive and negative curva-
tures should be more easily formed in GUVs, as reported for
penetratin with ﬂuid membrane domains [77].
Penetratin, Tat and R9 do not evoke liposome leakage [72,78]
but a primary amphipathic CPP such as TP10 can [79]. These data
show that different translocation mechanisms should explain the
differences in membrane behavior of CPPs.
2.2. Structural requirements for CPPs internalization
Though not speciﬁcally required for the cellular uptake, the
electrostatic interaction of basic CPPs with the negatively charged
proteoglycans and phospholipids on the cell surface is generally
acknowledged to be the ﬁrst step for the cellular entry [80–84].
Moreover, membrane binding and insertion is also an important
feature of CPPs, especially amphipathic ones, which can lead to
endocytic pathways or direct translocation [66,85,86]. Interaction
with the different components of the plasma membrane, be it elec-
trostatic or hydrophobic, is strongly controlled by the positive
charge number and density, the hydrogen bonds, the size and the
secondary structure of the peptides [87–89].
2.2.1. Positive charge and ‘‘Magic Arginine’’
Since the cell wall constitute an array of negative charges, CPPs
generally exploit their basic residues in order to drive their way in-
side the cell. Thus, the logical ﬁrst interaction between the posi-
tively charged CPPs and the plasma membrane is of electrostatic
nature, where the peptides will bind to the negatively charged
polysaccharides and lipids before ﬁnding their way to the internal-
ization active membrane sites. In fact, the role of the positive
charge in enhancing the uptake of macromolecules was demon-
strated a long time ago, when Ryser and Hancock found that the
uptake of albumin by tumor cells was boosted if the protein is
mixed with high molecular weight poly-lysines [90]. This crucial
role of positively charged residues was then proved for different
CPPs sequences. For instance, truncation or alanine substitution
of any of the charged residues within the basic region of Tat pep-
tide markedly reduced the rate of uptake [91], and a decrease in
the uptake of penetratin was also observed after alanine scanning
of the basic residues [92].
A closer look led to the ﬁnding that arginine residues were more
effective in terms of internalization than lysines, and that replacing
lysine residues with arginine increased the rates of the uptake
[14,91]. Thus, the uptake efﬁciency is attributed to the guanidi-
nium headgroup of the arginine side chain rather than to the posi-
tive charge alone [93,94]. Moreover, it was demonstrated that the
number of arginine residues is also crucial, with polyarginines of
7–15 residues presenting an optimal uptake [14,15].In fact, the guanidinium group forms bidentate hydrogen bonds
with negatively charged phosphate, sulfate and carboxylate
groups on the cell surface, in contrast to the situation with ammo-
nium cations in lysines that can donate only one hydrogen bond.
This will result in counteranion scavenging that will help attenu-
ating the polarity of the guanidinium group by producing a polar
ion pair complex capable of diffusing into the membrane [93]. In
oligo/polymers, this counteranion scavenging will also help in
attenuating charge repulsion between nearby guanidinium enti-
ties, while in the case of nearby ammonium groups the charge
repulsion is attenuated by reduction of pKa values. This will result
in thermodynamically more stable complexes between oligo/poly-
arginines compared to monoarginines [95]. Moreover, Sakai et al.
further demonstrated that the counteranion-mediated phase
transfer of oligoarginine from water into chloroform was more
efﬁcient at a cation/anion ratio of 2 [96], and that phosphate and
sulfate counteranions were more efﬁcient than carboxylate in
mediating phase transfer. Various other theoretical studies shed
the light on the importance of guanidinium–phosphate interac-
tions and the physico-chemical state of the arginine-side chain
[97,98].
2.2.2. Hydrophobicity and ‘‘Tryptophan Power’’
Hydrophobic residues, when present in the sequences of CPPs,
play a major role in the interaction with the plasma membrane bi-
layer and thus are thought to enhance the peptide translocation
across this membrane [99–101]. For instance, any single residue
mutation of the N-terminal hydrophobic sequence of pVEC peptide
(LLILL) led to a decrease of the cellular uptake of this CPP [100]. On
the other hand, vesicle leakage was induced when adding a trypto-
phan residue or a ﬂuorescein isothiocyanate (FITC) dye to the unla-
beled sequences of R6 and Tat peptide, showing that changes in
hydrophobicity strongly affected the translocation mechanism
[41]. Nevertheless, the hydrophobic character should be taken with
caution because deeper insertion in the lipid membrane might lead
to a less efﬁcient internalization, probably because the peptides
will be stuck in the plasma membrane [102,103]. For instance, it
has been shown that the mutated (W48F,W56F)penetratin was
more deeply inserted than the wild type penetratin in the hydro-
phobic core of negatively charged bicelles [104]. Indeed, a minimal
ﬂexibility of the positively charged entities is required in order to
induce internalization.
Among hydrophobic residues, aromatic functional groups play
a role beyond hydrophobicity. Non-covalent interactions of aro-
matic p-electron density have been extensively studied and dem-
onstrated to be crucial for biological functions [105]. Aromatic
residues, especially tyrosine and tryptophan, are predominant at
the membrane surface of membrane proteins and were demon-
strated to have favorable free energies of insertion into the bi-
layer interface [106,107]. In addition, it was demonstrated that
tryptophan residues are involved in membrane destabilization
processes [108,109]. Tryptophan was found a crucial residue for
the uptake of CPPs, and its role was mainly assessed for the inter-
action with the lipid plasma membrane bilayer [17,85]. For in-
stance, alanine-scanning study conﬁrmed that except for Trp
residues, no particular hydrophobic residue is required for
penetratin internalization [92], while addition of a tryptophan
to the C-terminal end of R7 peptide enhanced the uptake of this
latter [110].
Recent studies have uncovered an extended role of Trp in the
mechanism of internalization of CPPs. Rydberg et al. have indeed
shown that increasing the number of Trp residues in oligoarginine
sequences enhances the uptake efﬁciency of the peptides, albeit
the afﬁnity of peptides for phospholipids is not affected [111]. In
this study, the uptake pattern differed between peptides with dif-
ferent tryptophan contents and compositions, showing both endo-
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also described that penetratin and PenArg (that contain two Trp
residues) binding to sulfated sugars is stabilized by hydrophobic
interactions and result in clustering of heparin [112]. We also dem-
onstrated a direct role of the number of Trp in the interaction with
sulfated sugars and in the internalization efﬁcacy of basic CPP se-
quences [60]. Thermodynamic data indicated that Trp residues
within basic peptide sequences increase the afﬁnity of these latter
for chondroitin (CS) and heparan sulfates (HS). These peptides also
adopt a b-strand structure in complex with CS and HS and lead to
the formation of large and stable aggregates. Basic peptides with-
out Trp are structured as a-helices in complex with CS and HS
and do not induce the formation of observable aggregates [60].
With regard to the molecular mechanisms of these interactions be-
tween CPP containing Trp residues and glycosaminoglycans
(GAGs), the ﬁrst binding step should involve ion-pair formation be-
tween all basic peptides and GAGs. Arg and Trp residues could con-
tact the sugar units either by electrostatic and bidentate hydrogen
bond interactions with the sulfates or by hydrophobic interactions
to the sugar rings, respectively. Trp residues may also bind to sul-
fate groups of GAGs, possibly through p–anion interactions [113–
116]. In addition, it is well-known that Trp and Arg side chains
from two different peptide b-strands can also interact through
p–cation non-covalent bonds and evoke self-assembly of peptides,
which should lead to the formation of b-sheet aggregates in com-
plex with GAGs. Finally, p–cation interactions between Trp and
Arg residues can modify the pKa of the guanidinium side chain
and increase the abundance of the protonated form of arginyl res-
idues, and thus the interaction of the peptide with negatively
charged GAGs [60].
2.2.3. Peptide secondary structure
The secondary structure of CPPs was mainly studied when
interacting with model membranes, in order to explain the mem-
brane perturbation and subsequent internalization. Mostly
unstructured in aqueous solution [66,85,86,102,117,118], CPPs
adopts various structures following the interaction with lipids. This
variability, even for the same sequence, is certainly a result of the
different experimental conditions employed such as: peptide/lipid
concentrations and ratios, buffer conditions (pH, ionic strength,
etc.), temperature, and others. In contact with model membranes,
Tat and short polyarginines remain unstructured, while penetratin
had been shown to adopt an a-helical structure [65,104,119–121]
and a b-strand or a b-turn conformation [122,123]. Although one
should remind that dynamics of peptide structure in cells might
be faster than time-resolved detection techniques, a recent in cell
Raman study showed that penetratin is mainly random coil and
b-strand in the cytoplasm, and b-sheet in the nucleus [35].
It is still not clear if a correlation between the peptide second-
ary structure and its ability to translocate exists. For instance, it
was shown that an a-helical structure is not necessary for the
internalization of penetratin [120,124]. What should be kept in
mind, however, is the importance of the structural ﬂexibility, as
observed by the group of Divita who suggested that the structural
polymorphism and malleability of CPPs could be important for the
membrane interaction and internalization route [88], and that
depending on the structure adopted the peptide will favor one
route of entry on another [86]. ‘‘Chameleon-like’’ properties at bio-
membrane surfaces were also described for penetratin by Mag-
zoub et al., where the authors suggested that the peptide,
generally random coiled in water, tends to fold into an a-helix
or to adopt a b-fold depending on the conditions [65]. Structural
polymorphism correlates with the fact that the peptides have to
interact with different lipid environments, and hence to adapt
their conformation, as suggested by Brasseur and co-workers
[125].2.3. Mechanisms of internalization of CPPs: one route for entry?
The ﬁrst reported studies for penetratin, Tat peptide and R9
indicated that these peptides enter the cells by a passive, temper-
ature- and receptor-independent process [5,6,15,124], which is not
sensitive to endocytosis inhibitors [5,126]. It was thus suggested
that the peptides are entering via direct translocation through
physical perturbation of the plasma membrane. But all these stud-
ies were based on confocal microscopy in ﬁxed cells, and it was la-
ter demonstrated that ﬁxation prior to confocal laser scanning
microscopy of cells incubated with ﬂuorescence-labeled CPP could
lead to artifactual results [38]. Since 2003 [38,127], an emphasis
has been given to the role of endocytosis in the uptake of CPPs,
but with different emerging techniques, it appeared that both
endocytosis and direct translocation across the plasma membrane
can occur at the same time [128]. In addition, recent studies sug-
gest that a receptor-mediated entry is not ruled out for some
CPP-conjugates. For instance, Ezzat et al. demonstrated that Pep-
Fect14 peptide forming non-covalent nano-complexes with ONs
enter HeLa cells through class-A scavenger receptors (SCARAs)
[129].
An important feature when summarizing the different mecha-
nisms described is the parameters that affect the uptake: the CPP
alone or coupled to a small or high molecular weight cargo, the
nature of the link between the peptide and the cargo, the cell line
used, the extracellular peptide concentration, the incubation
time, . . . [57,130,131]. It is thus difﬁcult to make a general rule
out of the speciﬁc experimental conditions published.
All the mechanisms used by CPPs to enter are somehow con-
nected and occur simultaneously, and the down-regulation of
one pathway might lead to an up-regulation of the other. In the fol-
lowing section, we have tried to summarize the various ﬁndings
regarding the cellular entry, with an emphasis on some of the most
studied peptides: penetratin, Tat and oligoarginine.
2.3.1. Endocytosis
Endocytosis of CPPs consists of two steps: endocytic entry fol-
lowed by endosomal escape. This latter is crucial in order to avoid
degradation of the cargo in lysosomes, and to enable the cargo to
reach its extra-endosomal target and exert its biological activity.
The favorable conditions for endosomal escape (e.g. the physico-
chemical properties of the CPPs) are not yet known, giving an addi-
tional reason for studying the various CPP/molecule interactions.
Endocytosis is a natural process occurring in all cells. It can be
triggered by electrostatic interactions with cell surface proteogly-
cans or by direct interaction with the plasma membrane. When
bound to GAGs, CPPs might enter following the recycling cycle of
GAGs that are constantly internalized [132,133], or more effec-
tively CPPs can trigger endocytosis via clustering of GAGs, activa-
tion of intracellular signals and actin remodeling [57,82,89,134].
All known types of pinocytic routes were described for the entry
of the different CPPs and mainly CPPs–cargo complexes.Macropin-
ocytosis: Macropinocytosis was demonstrated to be implicated in
the internalization of polyarginines [135], and to a much less ex-
tent of penetratin. These observations relied on the inhibition of
macropinosome formation by ethylisopropylamiloride (EIPA), and
of F-actin polymerization by cytochalasin D. Moreover, the authors
described an induced rearrangement of the actin cytoskeleton after
treatment of cells with R8, but no colocalization of R8 and R16 olig-
omers, suggesting different mechanisms implicated in the entry.
Later, Duchardt et al. demonstrated that macropinocytosis for R9
prevails at concentration less than 10 lM [130]. As for Tat peptide,
inhibiting macropinocytosis also led to a decrease in the uptake,
suggesting macropinocytosis as a route of entry [56,136].
A recent study [41] proposed that Tat can stimulate its own up-
take by macropinocytosis: they suggested that following internal-
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interact with the actin cytoskeleton which will trigger macropino-
cytosis. Other studies, however, reported that after binding and
clustering of proteoglycans, the peptides will induce activation of
a small GTPase, Rac1, which will result in actin remodeling and in-
duce macropinocytosis [137,138]. Finally, the group of Dowdy con-
ﬁrmed macropinocytosis as the route for Tat uptake, with the
necessity of the presence of plasma membrane active proteins
but not surface GAGs or sialic acids for the uptake [55].
Clathrin-mediated endocytosis: Clathrin-mediated endocytosis
was shown to be implicated for the uptake of penetratin, Tat pep-
tide and other CPPs after inhibition by hyperosmolar medium
[139]. Moreover, while various studies demonstrated the implica-
tion of clathrin dependent endocytosis for Tat peptide [140–142],
other suggested that the uptake of Tat was not affected by dynam-
in1, an inhibitor of clathrin-mediated endocytosis [136], and that
the uptake in clathrin knock-down cells was not affected [143].
Caveolae-mediated uptake: Caveolae-mediated uptake was also
demonstrated for some CPPs, such as Tat peptide that colocalized
with caveolae marker caveolin-1 [144], even though various other
studies gave contradictory results. For instance, treatment of HeLa
and Chinese hamster ovary (CHO) cells with nystatin and ﬁlipin III,
inhibitors of caveolae-dependent endocytosis, did not affect the
internalization of Tat peptide [140], and caveolin knock-out was
shown not to affect the uptake of Tat peptide in baby hamster kid-
ney cells [143]. Finally, raft-dependent endocytosis (caveolae-
dependent or not) was shown to also play a role in the internaliza-
tion of penetratin, Tat peptide and others [145].
Noteworthy, the distinction between the various endocytic
routes in most of the cited studies relied on the use of chemical
inhibitors (Table 2) and the detection of the colocalization of the
peptides with protein makers. Such methods can have negative
side effects, including poor speciﬁcity, high dependence on the cell
line used and even sometimes decrease in cell viability [146,147].
Thus, the interpretations of the results must be made with caution.
Direct translocation across the plasma membrane: Direct translo-
cation involves destabilization of the plasma membrane, in an en-
ergy- and temperature-independent manner. Evoked at ﬁrst as the
mechanism of internalization of CPPs, then refuted as an artifact of
ﬁxation, direct translocation was later conﬁrmed using ﬂuores-
cence in living cells, quantiﬁcation of the uptake at 4 C and in
the absence of endocytosis (e.g. ATP depletion) and using various
biophysical approached in model systems [57,71,148–150]. Note-
worthy, while endocytosis in inhibited at 4 C, direct translocation
is also decreased for membrane dynamics and ﬂuidity are affected
at such low temperature [151,152]. Thus, assessing direct translo-Table 2
Endocytic chemical inhibitors frequently used.
Inhibitor Mode of action
Clathrin-mediated endocytosis
Hyperosmolar conditions Dispersion of plasma membrane
Potassium depletion Clathrin lattices
Cytosolic acidiﬁcation
(NH4Cl; Chloroquine;
Baﬁlomycin A)
Inhibits the budding of clathrin-coated pits
Chlorpromazine Loss of clathrin and AP2 adaptor complex
from the cell surface
Macropinocytosis
Amilorides Inhibitors of Na+/H+ exchange
Cytochalasin D; Latrunculins Disassembly of the actin cytoskeleton
Lipid raft-dependent endocytosis (caveolae-dependent or not)
Methyl-b-cyclodextrin Cholesterol extraction
Nystatin; Filipin Cholesterol sequestration
Statins Inhibition of cholesterol synthesis
Clathrin- and caveolae-mediated endocytosis
Dynasore Inhibition of dynamin GTPase activitycation at low temperatures in living cells leads to an under-estima-
tion of this latter.
Various hypotheses were reported to explain direct transloca-
tion of CPPs across the lipid bilayer (Fig. 1).
Inverted micelle formation: Inverted micelle formation was ﬁrst
proposed to explain the direct translocation of penetratin [124]
(Fig. 1A). In this model, the basic residues will interact with the
negatively charged phospholipids in the plasma membrane, and
the subsequent interaction of hydrophobic residues with the mem-
brane core induces the destabilization of the bilayer forming a neg-
ative curvature (i.e. invagination of the membrane) [66]. The
concomitant reorganization of the neighboring lipids [153] leads
to the formation of the inverted micelle that encapsulates the pep-
tide(s) in its interior. Membrane disruption releases the peptide in
the intracellular side. Substitution of tryptophan residues by phen-
ylalanine inhibited the formation of inverted micelles, as revealed
by 31P-NMR experiments [117], showing an important role of this
residue in the interaction with the bilayer, not only in terms of
hydrophobicity. Molecular dynamic simulation further demon-
strated the inverted micelle hypothesis, with an emphasis on the
role of hydrogen bonding between the guanidinium headgroups
and phosphate groups [154]. Various other studies describe mem-
brane deformation (tubulation, multivesicular structures) upon the
interaction of CPPs with model and cellular membranes [34,155].
Adaptive translocation: The capacity of guanidinium headgroups
to form bidentate hydrogen bonds will give oligoarginines either a
hydrophilic or hydrophobic character depending on the associated
counteranion. Based on this capacity, the interaction between
guanidinium-rich peptides and the phosphate lipid headgroups
will mask the peptide charge, attenuating its polarity and enabling
its adaptive diffusion into and across the membrane [156] (Fig. 1C).
This diffusion is driven by the membrane potential of the plasma
membrane [93], thus the peptide should carry a positive net
charge. This explains the fact that a minimum number of arginine
residues is necessary to observe internalization.
Pore-formationmodel: Molecular dynamic simulations and elec-
trophysiology experiments [157,158] evoked the formation of
transient toroidal pores that will enable the passive diffusion of
Tat and arginine-rich peptides across the plasma mem-
brane(Fig. 1B). Brieﬂy, the interaction between the positive side
chains and the phosphate groups leads to the accumulation of
the peptides in the outer leaﬂet, positioned between the phosphate
and the carbon chains of the lipids. The accumulation of the pep-
tides causes a thinning of the bilayer, and the attraction between
the side chains of arginine and lysine and the headgroups of the
distal layer leads to the formation of a transient pore through
which other peptides diffuse carrying with them the attached
phospholipids. This evokes that the length of the side chain of argi-
nine residues also contributes to the more efﬁcient insertion and
translocation compared to the lysine side chains [91]. Studies with
other CPPs, based in addition on ﬂuorescence and calorimetric
methods, also suggested the formation of transient pores as a
mechanism of direct translocation [79,159–161]. Palm-Apergi
et al. proposed that the disturbance of the plasma membrane in-
duced by the formation of the pores will trigger the membrane re-
pair response (MRR) induced by the calcium efﬂux into the cells.
Internal vesicles will fuse together and serve as a patch to reseal
the membrane [33].
Electroporation-like permeabilization: Electroporation-like per-
meabilization was described by Binder and Lindblom for the direct
passage of penetratin across negatively charged membranes. They
suggest that above a threshold peptide concentration, the asym-
metric charge distribution between the outer and the inner com-
partments will cause a transmembrane electrical tension. The
membrane is thus permeabilized in an electroporation-like man-
ner which creates transient defects that enable the peptides to
Fig. 1. Examples of the proposed mechanisms for direct translocation. (A) Inverted micelle formation. (B) Pore-formation. (C) Adaptive translocation.
C. Bechara, S. Sagan / FEBS Letters 587 (2013) 1693–1702 1699distribute to both leaﬂets [149]. Indeed penetratin was shown to
remain at the interface between the phospholipid bilayer and the
aqueous medium without a deep insertion into model membranes
[162]. This mechanism was later disputed by Su et al. [123] who
demonstrated by solid-state NMR that penetratin was distributed
in both leaﬂets even at low peptide concentration.
Entry at microdomains boundaries: Regions between different
membrane domains can have packing defects that are more sus-
ceptible for peptide entrance or can act as nucleation sites for pore
formation. These domains can be formed by the preferential inter-
action of the peptide with anionic lipids for example, which will
lead to a reorganization of the plasma membrane [153]. Another
possibility was evoked by the group of Brock, relying on the action
of acid sphingomyelinase (ASMase) that will translocate to the
extracellular leaﬂet of the plasma membrane and hydrolyses SM,
thus creating ceramide-enriched domains. CPPs are believed to en-
ter at the interface between these domains and the bulk of the
plasma membrane [163].
3. Perspectives
Although the exact mechanisms of CPP internalization is still
indecisive, several studies pointed to the importance of the interac-
tion with, and the clustering of, GAGs or negatively charged phos-
pholipids in the internalization of CPPs [57,59,60,80,134,164–166].
On one side, with the use of cell lines devoid of certain types of
GAGs, and the concomitant observation of decreased internaliza-
tion efﬁcacy, the implication of GAGs in internalization of CPPs is
no longer questioned in the ﬁeld [26,55,57,164]. Exploiting GAGs
as a portal to the cytoplasm of cells deserve however more studies
on the intracellular trafﬁc and fate of CPPs or CPP-cargoes.
When CPPs enter through endocytosis, endosomal escape, thus
membrane translocation, occurs within cells and releases CPPs into
the cytosol [167–172]. Endosomal escape would involve phospho-
lipid clustering as a ﬁrst transient membrane destabilization step,
as antimicrobial peptides do to exert their toxic action [166]. Direct
translocation of CPPs at the plasma membrane would occur pri-
marily through negative curvature formation [48] or at membrane
domain boundaries [163]. Albeit several recent studies brought
strong data for the existence of direct membrane translocation[34,41,57,60,71,173–175], a better physical description of these
mechanisms of entry in cells is still an open challenge for the next
years.
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